Johnson Matthey PLC
26 January 2006
For Release at 9.15 am on Thursday 26th January 2006
Johnson Matthey Trading Update
Johnson Matthey is hosting an analysts' visit today at its Pharmaceutical
Materials business in Edinburgh. At the meeting Neil Carson, Chief Executive of
Johnson Matthey, gave the following update on current trading:
"Trading in the second half of Johnson Matthey's financial year is progressing
in line with expectations. Catalysts Division continues to perform well with
Environmental Catalysts and Technologies (ECT) benefiting from growth in diesel
emission control products in Europe. Demand for autocatalysts in the USA
remains weak but sales in China and Japan are well up on last year. Overall ECT
is on track to achieve 10% growth in profits in the second half. Process
Catalysts and Technologies (PCT) is also expected to achieve good growth for the
year led by the Ammonia, Methanol, Oil and Gas (AMOG) catalyst business. Sales
of catalysts for hydrogen generation and gas purification have been particularly
strong.
Precious Metal Products Division has had a good third quarter and should benefit
from the strong platinum price which rose above $1,000/oz earlier this month.
Pharmaceutical Materials Division's sales were up in the third quarter and
profits in the second half should be ahead of the first. Ceramics Division has
maintained the improvement achieved in the first half and should deliver good
profit growth for the year.
Overall, the outlook for the full year remains very much the same as we set out
in our interim statement. Following an encouraging first half we are expecting
to achieve good growth in earnings for the year."
Enquiries:
Ian Godwin Director, IR and Corporate Communications 020 7269 8410
John Sheldrick Group Finance Director 020 7269 8438
Howard Lee The HeadLand Consultancy 020 7367 5225
www.matthey.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.